FOR LABORATORY & RESEARCH USE ONLY — NOT FOR HUMAN OR VETERINARY USE
Call us+1 (855) 961-4043
Account
HomeProductsTriple AgonistsGLP-3 (RT) 30 mg
Triple Agonists

GLP-3 (RT) 30 mg

Research compound

No reviews yet
Select size
10 mg20 mg30 mg
≥99% purity

Product Information

Research-focused notes for GLP-3 (RT), organized for quick review without adding ecommerce density.

GLP-3 (RT) Product Overview

A 39-amino acid triple agonist peptide targeting GIP, GLP-1, and glucagon receptors, studied for metabolic regulation and body composition in clinical research.

Also known as: LY3437943, GLP-3.

For laboratory and research use only. Not for human or veterinary use. Not for diagnostic procedures. This product has not been evaluated by the FDA.

Certificate of Analysis

Third-party testedPublished certificates
LAB TESTED
PURITY99.4%Passed full QC panel
5×TESTED
Variant
GLP-3 (RT) 10 mg
Lot #
SAMPLE-LOT-PEPTIDE-GALA-GLP-3-RT-1
Labelled
10 mg
Actual
10 mg
Tested
Oct 12, 2026
Status
Latest

FULL QC PANEL

SAMPLE DATA — not a real laboratory
Identity
Confirmed (sample data)
Purity (HPLC)
99.4%
Net content
10 mg
Appearance
Sample data
Endotoxin
Sample data
LAB TESTED
PURITY98.7%Passed full QC panel
5×TESTED
Variant
GLP-3 (RT) 10 mg
Lot #
SAMPLE-LOT-PEPTIDE-GALA-GLP-3-RT-2
Labelled
10 mg
Actual
10 mg
Tested
May 12, 2026
Status
Previous

FULL QC PANEL

SAMPLE DATA — not a real laboratory
Identity
Confirmed (sample data)
Purity (HPLC)
98.7%
Net content
10 mg
Appearance
Sample data
Endotoxin
Sample data
LAB TESTED
PURITY99.1%Passed full QC panel
5×TESTED
Variant
GLP-3 (RT) 20 mg
Lot #
SAMPLE-LOT-PEPTIDE-GALA-GLP-3-RT-3
Labelled
20 mg
Actual
20 mg
Tested
Dec 12, 2025
Status
Previous

FULL QC PANEL

SAMPLE DATA — not a real laboratory
Identity
Confirmed (sample data)
Purity (HPLC)
99.1%
Net content
20 mg
Appearance
Sample data
Endotoxin
Sample data
LAB TESTED
PURITY98.9%Passed full QC panel
5×TESTED
Variant
GLP-3 (RT) 20 mg
Lot #
SAMPLE-LOT-PEPTIDE-GALA-GLP-3-RT-4
Labelled
20 mg
Actual
20 mg
Tested
Jul 12, 2025
Status
Previous

FULL QC PANEL

SAMPLE DATA — not a real laboratory
Identity
Confirmed (sample data)
Purity (HPLC)
98.9%
Net content
20 mg
Appearance
Sample data
Endotoxin
Sample data
LAB TESTED
PURITY99.6%Passed full QC panel
5×TESTED
Variant
GLP-3 (RT) 30 mg
Lot #
SAMPLE-LOT-PEPTIDE-GALA-GLP-3-RT-5
Labelled
30 mg
Actual
30 mg
Tested
Feb 12, 2025
Status
Previous

FULL QC PANEL

SAMPLE DATA — not a real laboratory
Identity
Confirmed (sample data)
Purity (HPLC)
99.6%
Net content
30 mg
Appearance
Sample data
Endotoxin
Sample data
LAB TESTED
PURITY98.5%Passed full QC panel
5×TESTED
Variant
GLP-3 (RT) 30 mg
Lot #
SAMPLE-LOT-PEPTIDE-GALA-GLP-3-RT-6
Labelled
30 mg
Actual
30 mg
Tested
Sep 12, 2024
Status
Previous

FULL QC PANEL

SAMPLE DATA — not a real laboratory
Identity
Confirmed (sample data)
Purity (HPLC)
98.5%
Net content
30 mg
Appearance
Sample data
Endotoxin
Sample data
Batch certificates for the selected size

Compound Information

Technical specifications

Molecular profile

What is GLP-3 (RT)

CAS Number2381089-83-2
Storage requirements

Stability Information

Selected variant30 mg
Lyophilized-20°C · 24+ months
Reconstituted2-8°C · ~30 days
HandlingAvoid freeze/thaw cycles · Protect from light · Keep refrigerated
UseResearch purposes only
Purity≥99%
Product FAQ

GLP-3 (RT) research questions

Concise answers generated from this product's current catalog description, variants, specifications, and handling data.

A 39-amino acid triple agonist peptide targeting GIP, GLP-1, and glucagon receptors, studied for metabolic regulation and body composition in clinical research.

Continue researching

Related compounds

Other listings researchers in this category often review together.

View all compounds